The “vast majority” of members
of the Pharmaceutical Society
of Australia are satisfied or very
satisfied with many aspects of
their membership, according to a
survey of 1,500 pharmacists across
Australia conducted in Aug.
97% of respondents rated the
provision of CPD and learning
resources as an important or critical
function of PSA, with 91% in total
satisfied or extremely satisfied with
PSA’s delivery of CPD.
PSA ceo Lance Emerson said
the survey also found 76% of
respondents believed membership
of PSA was “important or critical”
to being a successful pharmacist.
In the survey members also
strongly encouraged PSA to do
more about key issues including
inadequate remuneration,
competition from discounters and
oversupply of pharmacists.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Nov 15
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.